Latest News

Emergency gout admission increase is ‘call to arms’

Publish date: May 30, 2018

 

AT RHEUMATOLOGY 2018

SOURCE: Russel M et al. Rheumatology. 2018;57[Suppl. 3]:key075.186; Whiteman J, et al. Rheumatology. 2018;57[Suppl. 3]:key075.215.

Pages

Recommended Reading

For acute gout, corticosteroids look safer than NSAIDs
MDedge Family Medicine
FDA approves once-daily treatment for hyperuricemia in gout
MDedge Family Medicine
Allopurinol extension trial backs treat-to-target approach in gout
MDedge Family Medicine
Febuxostat prevents early gout flares
MDedge Family Medicine
Gout incidence is intertwined with serum urate, but only up to a point
MDedge Family Medicine
FDA: Febuxostat may have increased heart-related death risk
MDedge Family Medicine
Higher water intake linked to less hyperuricemia in gout
MDedge Family Medicine
Health disparities in rural America: Chronic conditions
MDedge Family Medicine
Febuxostat increases cardiovascular mortality in CARES trial
MDedge Family Medicine
Allopurinol dose not escalated enough to reduce mortality
MDedge Family Medicine

Related Articles